Diabetes mellitus is a kind of chronic comprehensive disease mainly caused by glucose metabolism disorder due to absolute or relative deficiency of insulin or decreased insulin sensitivity of target cells. The occurrence of type 2 diabetes mellitus is a combination of peripheral insulin resistance and ? cell dysfunction. the result of. When diabetes patients undergo diet and exercise therapy and diabetes care education, blood glucose control can still not reach the treatment goals, the need for drug treatment-Antidiabetic Drug Scope of the Report: This report focuses on the Antidiabetic Drug in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application. The global anti-diabetic drug market is expected to witness significant growth during the forecast period. This growth is attributed due to increasing prevalence of diabetes and rising demand for oral anti-diabetic drugs. In addition, sedentary lifestyle, increasing the percentage of obesity, high-stress levels are considered as a major driving factor for the growth of oral anti-diabetic drugs market. Furthermore, technological advancement and medical reimbursements can also help in fuelling the growth of oral antidiabetic drug market. However, the high cost of drugs is considered as a major restraint for the market. Nonetheless ongoing research and huge market potential can bring growth opportunities for anti-diabetic market within the forecast period. Based on the class of drug, the global anti-diabetic drug market is segmented into five types: sulfonylureas, meglitinides, biguanides, alpha-glucosidase inhibitors and others. Sulphonylureas segment of oral anti-diabetic drugs market accounted for the largest market share in 2018followed by biguanides derivatives. Sulfonylureas were the largest segment and acquired around 37% of world market share followed by biguanide derivatives in 2018 Sulfonylureas are a class of organic compounds used in medicine and agriculture. They are antidiabetic drugs widely used in the management of type 2 diabetes mellitus. They act by increasing insulin release from the beta cells in the pancreas. The worldwide market for Antidiabetic Drug is expected to grow at a CAGR of roughly 9.0% over the next five years, will reach 76300 million US$ in 2023, from 49600 million US$ in 2017, according to a new GIR (Global Info Research) study. Market Segment by Manufacturers, this report covers Sanofi-Aventis Eli Lilly Oramed Takeda Boehringer Ingelheim Novo Nordisk Halozyme Therapeutics Bristol-Myers Squibb Pfizer Tonghua Dongbao Biocon Wockhardt Market Segment by Regions, regional analysis covers North America (United States, Canada and Mexico) Europe (Germany, France, UK, Russia and Italy) Asia-Pacific (China, Japan, Korea, India and Southeast Asia) South America (Brazil, Argentina, Colombia etc.) Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Market Segment by Type, covers Alpha-Glucosidase Inhibitors Biguanides, Sulphonylureas Glp-1 Agonist Meglitinides Dpp-4 Inhibitors Sglt?2 Thiazolodinediones Market Segment by Applications, can be divided into Type I Diabetes Type II Diabetes There are 15 Chapters to deeply display the global Antidiabetic Drug market. Chapter 1, to describe Antidiabetic Drug Introduction, product scope, market overview, market opportunities, market risk, market driving force; Chapter 2, to analyze the top manufacturers of Antidiabetic Drug, with sales, revenue, and price of Antidiabetic Drug, in 2016 and 2017; Chapter 3, to display the competitive situation among the top manufacturers, with sales, revenue and market share in 2016 and 2017; Chapter 4, to show the global market by regions, with sales, revenue and market share of Antidiabetic Drug, for each region, from 2013 to 2018; Chapter 5, 6, 7, 8 and 9, to analyze the market by countries, by type, by application and by manufacturers, with sales, revenue and market share by key countries in these regions; Chapter 10 and 11, to show the market by type and application, with sales market share and growth rate by type, application, from 2013 to 2018; Chapter 12, Antidiabetic Drug market forecast, by regions, type and application, with sales and revenue, from 2018 to 2023; Chapter 13, 14 and 15, to describe Antidiabetic Drug sales channel, distributors, traders, dealers, Research Findings and Conclusion, appendix and data source
Table of Contents 1 Market Overview 1.1 Antidiabetic Drug Introduction 1.2 Market Analysis by Type 1.2.1 Alpha-Glucosidase Inhibitors 1.2.2 Biguanides, Sulphonylureas 1.2.3 Glp-1 Agonist 1.2.4 Meglitinides 1.2.5 Dpp-4 Inhibitors 1.2.6 Sglt?2 1.2.7 Thiazolodinediones 1.3 Market Analysis by Applications 1.3.1 T
